siRNA-loaded exosomes targeting KRAS G12C (Exollence Biotechnology)

N/A

Report date: 2025/05/19 16:13:00
NME

Base Information

Drug NamesiRNA-loaded exosomes targeting KRAS G12C (Exollence Biotechnology)
Drug Alias NameKRAS G12C siRNA-loaded exosomes
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionKRAS G12C inhibitors
TargetsKRAS G12C
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExollence Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesExollence Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A